Charaterization of bumarsin, a 3-hydroxy-3-methylglutaryl-coenzyme reductase inhibitor from Mesobuthus martensii Karsch venom

Toxicon : Official Journal of the International Society on Toxinology
S C ChaiK Jeyaseelan

Abstract

Scorpion venoms are rich sources of bioactive peptides and are widely known for their ion channel inhibiting properties. We have isolated, cloned and characterized a venom protein (Bumarsin) from the Chinese scorpion, Mesobuthus martensii Karsch. Bumarsin cDNA encodes a 8132 Da, 72 amino acid mature protein that most probably exists in its native form as a Cys-bridged homodimer. We have identified this novel protein to be an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity. 0.6 μM of Bumarsin inhibits 32% of the HMG-CoA reductase activity, in comparison to 10 μM simvastatin which only inhibits 35% of the activity. RT-PCR and SELDI-TOF mass spectrometric studies demonstrate that bumarsin regulates the expression of both genes and proteins involved in cholesterol homeostasis. Our results suggest that bumarsin may provide a model for the design of novel drugs that can be used to modulate cholesterol homeostasis.

References

Jan 1, 1997·Toxicon : Official Journal of the International Society on Toxinology·A ArmugamK Jeyaseelan
Oct 3, 1998·The Journal of Biological Chemistry·Y HuangR W Mahley
Apr 13, 1999·Gastroenterology Clinics of North America·Z R VlahcevicR T Stravitz
Sep 14, 1999·The American Journal of Medicine·J D Brunzell, J E Hokanson
May 16, 2001·Current Opinion in Lipidology·N S Shachter
Mar 30, 2002·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Shunyi Zhu, Wenxin Li
Sep 11, 2002·Toxicon : Official Journal of the International Society on Toxinology·Cyril GoudetJan Tytgat
Sep 24, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Shunlin RenWilliam M Pandak
Mar 22, 2005·Current Drug Targets. Immune, Endocrine and Metabolic Disorders·P R Manna, D M Stocco
Mar 22, 2005·The International Journal of Biochemistry & Cell Biology·Karine HuardLouise Brissette
Jun 25, 2005·Circulation Research·Gary F Lewis, Daniel J Rader
Mar 3, 2006·The Journal of Clinical Investigation·Noam Zelcer, Peter Tontonoz
Jul 11, 2006·The Journal of Clinical Investigation·Colin R Jefcoate
Jul 11, 2006·The Journal of Clinical Investigation·Carolyn L CumminsJean-Marc A Lobaccaro
Nov 11, 2006·Circulation Research·John F Oram, Ashley M Vaughan

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.